Published in Pharma Law Weekly, December 26th, 2006
This trend article about University of Oxford, U.K., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A competitive peptide enzyme immunoassay is highly sensitive for identifying persons with HIV-1 subtype C infection.
"V3 serotyping is a technique for determining HIV-1 genetic subtype based on the binding of antibodies from patient sera or plasma to synthetic V3 peptides derived from subtype consensus sequences.
"Variation in the performance of this assay has been attributed to V3 sequence heterogeneity,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-12-26)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.